The Office of Technology Transfer is a service department that works with investigators within The Feinstein Institute for Medical Research and the greater North Shore-LIJ Health System to facilitate the patent protection and further development of technologies developed by our staff.
In February, 2012 The Feinstein Institute and The Cleveland Clinic entered into an Alliance Agreement. This new Innovation Alliance – only the second one of its kind in the US – will leverage the entrepreneurial expertise of Cleveland Clinic, the research strengths of the Feinstein Institute and the capabilities of the entire North Shore-LIJ Health System to help turn the discoveries made at The Feinstein into diagnostic and treatment options for future patient care.
Developing new medications to treat patients is a lot of work. In this video, learn about all of the steps necessary to bring new therapies developed in medical research all the way into clinical care.
For over a decade, Cleveland Clinic Innovations (CCI) has earned a reputation as an industry leader in creating a uniquely inclusive environment that has been successful in commercializing medical devices, diagnostic and therapeutic drugs and healthcare-related information technologies. This model has resulted in 35 spin-off companies and more than $500 million in equity investment.
Prior to the formation of this alliance, breakthroughs at The Feinstein Institute over the last 10 years have led to the creation of 11 start-up companies. The Feinstein Institute now has more than 200 active patents that comprise 80 distinct technologies.
In addition to advancing discoveries to market, the Office of Technology Transfer is available to assist in the following areas:
- Negotiation of License agreements
- Materials transfer agreements (MTAs)
- Confidentiality Agreements (CDAs)